Serum Institute of India hopes to launch a COVID-19 vaccine every quarter: CEO
The vaccine maker hoped to supply 100 crore doses by the end of this year, said Serum Institute of India CEO Adar Poonawalla
'We are scaling up at the moment in India, will supply to other countries by end-January,' Poonawalla told
To fight against novel coronavirus, Serum Institute of India aimed to launch a new COVID-19 vaccine every quarter, chief executive officer Adar Poonawalla said on Thursday, news agency Reuters reported. Pune-based drugmaker joined hands with British-Swedish pharma giant AstraZeneca to manufacture one hundred crore doses of COVID-19 vaccine developed by the University of Oxford. Indian drug regulator earlier granted emergency authorisation for Covishield, the local version of Oxford-AstraZeneca COVID-19 vaccine, by Serum Institute of India.